Cargando...
Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling
BACKGROUND: Anti TNF drugs have been widely used in rheumatoid arthritis (RA) but only 70 to 80 % of patients respond to this therapy. Exploring the mode of action of anti-TNF drugs remains important in order to improve the efficiency of the treatment and enhance our knowledge of inflammation. TNF-α...
Guardado en:
| Publicado en: | Arthritis Res Ther |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774095/ https://ncbi.nlm.nih.gov/pubmed/26932562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0955-8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|